These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12585761)

  • 1. New biotechnology approvals for 2002.
    Piascik P
    J Am Pharm Assoc (Wash); 2003; 43(1):116-7. PubMed ID: 12585761
    [No Abstract]   [Full Text] [Related]  

  • 2. The biotech drug market.
    Lawrence S
    Nat Biotechnol; 2004 Dec; 22(12):1496. PubMed ID: 15583645
    [No Abstract]   [Full Text] [Related]  

  • 3. 2003 approvals: a year of innovation and upward trends.
    Frantz S
    Nat Rev Drug Discov; 2004 Feb; 3(2):103-5. PubMed ID: 15040573
    [No Abstract]   [Full Text] [Related]  

  • 4. Pipelines turn to biotech.
    Lawrence S
    Nat Biotechnol; 2007 Dec; 25(12):1342. PubMed ID: 18066015
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA new drug approvals in 2003.
    Wynn RL
    Gen Dent; 2004; 52(4):294-8, 300. PubMed ID: 15366292
    [No Abstract]   [Full Text] [Related]  

  • 6. The origins of new drugs.
    Kneller R
    Nat Biotechnol; 2005 May; 23(5):529-30. PubMed ID: 15877061
    [No Abstract]   [Full Text] [Related]  

  • 7. Biotech hits regulatory doldrums.
    Lawrence S
    Nat Biotechnol; 2005 Jun; 23(6):644. PubMed ID: 15940226
    [No Abstract]   [Full Text] [Related]  

  • 8. Biotech drug market steadily expands.
    Lawrence S
    Nat Biotechnol; 2005 Dec; 23(12):1466. PubMed ID: 16333279
    [No Abstract]   [Full Text] [Related]  

  • 9. 1999 a disappointing year for biotech approvals.
    Piascik P
    J Am Pharm Assoc (Wash); 2000; 40(2):269-70. PubMed ID: 10730031
    [No Abstract]   [Full Text] [Related]  

  • 10. Monoclonal antibodies market.
    Reichert J; Pavolu A
    Nat Rev Drug Discov; 2004 May; 3(5):383-4. PubMed ID: 15152631
    [No Abstract]   [Full Text] [Related]  

  • 11. Biopharmaceuticals: recent approvals and likely directions.
    Walsh G
    Trends Biotechnol; 2005 Nov; 23(11):553-8. PubMed ID: 16051388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in development and approval times for new therapeutics in the United States.
    Reichert JM
    Nat Rev Drug Discov; 2003 Sep; 2(9):695-702. PubMed ID: 12951576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Researchers see a need for speed in EU trial approvals.
    Cressey D
    Nat Med; 2008 Aug; 14(8):794. PubMed ID: 18685580
    [No Abstract]   [Full Text] [Related]  

  • 14. New IGF drug stirs competition in growth factor segment.
    Ratner M
    Nat Biotechnol; 2005 Oct; 23(10):1192. PubMed ID: 16211044
    [No Abstract]   [Full Text] [Related]  

  • 15. [Investigation on new molecular entities of drugs approved in three regions, Japan, U.S. and EU--common and preceding approvals in current 4 years].
    Saito M; Hirata-Koizumi M; Miyake S; Hasegawa R
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2006; (124):80-2. PubMed ID: 17405529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Under surveillance.
    Nat Biotechnol; 2005 Jan; 23(1):1. PubMed ID: 15637596
    [No Abstract]   [Full Text] [Related]  

  • 17. The rise (and decline?) of biotechnology.
    Kinch MS
    Drug Discov Today; 2014 Nov; 19(11):1686-1690. PubMed ID: 24747562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Financial anatomy of neuroscience research.
    Dorsey ER; Vitticore P; De Roulet J; Thompson JP; Carrasco M; Johnston SC; Holloway RG; Moses H
    Ann Neurol; 2006 Dec; 60(6):652-9. PubMed ID: 17192926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hasty approval, more withdrawals.
    Prescrire Int; 2005 Aug; 14(78):144. PubMed ID: 16106597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First inhalable insulin approved.
    Katsnelson A
    Nat Biotechnol; 2006 Apr; 24(4):369-70. PubMed ID: 16601705
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.